Jordan R Hill1, Zélia M Corrêa1. 1. Department of Ophthalmology, College of Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
Abstract
PURPOSE: The aim of this study was to describe the side effects of I-125 brachytherapy in the treatment of uveal melanoma. METHODS: This study was conducted as a case report. RESULTS: We report a case of scleral necrosis and protruding episcleral mass following the treatment of uveal melanoma with I-125 brachytherapy. CONCLUSIONS: Scleral necrosis after plaque radiotherapy can clinically simulate tumor recurrence with extraocular extension. The management of uveal melanoma requires a careful clinical follow-up, weighing the implications of treatment morbidity and mortality.
PURPOSE: The aim of this study was to describe the side effects of I-125 brachytherapy in the treatment of uveal melanoma. METHODS: This study was conducted as a case report. RESULTS: We report a case of scleral necrosis and protruding episcleral mass following the treatment of uveal melanoma with I-125 brachytherapy. CONCLUSIONS:Scleral necrosis after plaque radiotherapy can clinically simulate tumor recurrence with extraocular extension. The management of uveal melanoma requires a careful clinical follow-up, weighing the implications of treatment morbidity and mortality.